Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclomethasone/Salbutamol Combination Therapy in Mild Persistent Asthma
NCT00382889Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Aug 2002
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of beclomethasone dipropionate and salbutamol in asthma (4 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Mean value of morning Peak Expiratory Flow. Started Aug 2002; status: completed.
02
Drugs
beclomethasone dipropionatesalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00382889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00382889.